For: | do Prado-Lima PAS, Costa-Ferro ZSM, Souza BSF, da Cruz IBM, Lab B. Is there a place for cellular therapy in depression? World J Psychiatr 2021; 11(9): 553-567 [PMID: 34631460 DOI: 10.5498/wjp.v11.i9.553] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v11/i9/553.htm |
Number | Citing Articles |
1 |
Erhan Kavakbasi, Evelien Van Assche, Kathrin Schwarte, Christa Hohoff, Bernhard T. Baune. Long-Term Immunomodulatory Impact of VNS on Peripheral Cytokine Profiles and Its Relationship with Clinical Response in Difficult-to-Treat Depression (DTD). International Journal of Molecular Sciences 2024; 25(8): 4196 doi: 10.3390/ijms25084196
|
2 |
Takahiro Honda Pazili, Isabella Laura Simone. A Severe Alzheimer’s Disease Patient Improved by Intravenous Mesenchymal Stem Cell Transplant. Case Reports in Neurological Medicine 2024; 2024(1) doi: 10.1155/2024/8353492
|
3 |
Shu Wang, Yu-Guang Guan, Yan-Hua Zhu, Min-Zhong Wang. Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective. World Journal of Psychiatry 2022; 12(6): 779-786 doi: 10.5498/wjp.v12.i6.779
|
4 |
Shahrzad Nazari, Seyed Mahmoud Pourmand, Elahe Motevaseli, Gholamreza Hassanzadeh. Mesenchymal stem cells (MSCs) and MSC‐derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome. IUBMB Life 2023; 75(10): 794 doi: 10.1002/iub.2759
|